Non-Alcoholic Fatty Liver Disease (NAFLD) is a growing health concern, often overlooked by healthcare professionals.
NAFLD affects approximately 25% of the global population, making it the most common liver disorder worldwide.
NAFLD is characterized by excessive hepatic fat accumulation, not caused by alcohol. Its progression can lead to Non-Alcoholic Steatohepatitis (NASH), fibrosis, cirrhosis, and hepatocellular carcinoma.
Proactive management includes lifestyle modifications, pharmacotherapy, and regular monitoring to prevent progression.
Understanding NAFLD's prevalence, pathophysiology, and management strategies is crucial for effective patient care.
1.
Alzheimer's Blood Test Gets FDA Clearance
2.
The prognosis of the Slovakian PM; Kate Middleton's treatment; and drug test cheating.
3.
Imfinzi + Imjudo, EU approved for patients with advanced lung cancer and non-small cell lung cancer: AstraZeneca
4.
New Clues to Origin of T-Cell Lymphoma After CAR-T Therapy
5.
AI tool identifies women at high risk of interval breast cancer
1.
Personalized Survivorship Navigation in Precision Cancer Care
2.
The Silent Danger of Hematoma: How to Identify and Treat This Potentially Serious Condition
3.
Evolution of Cancer Care Through Developmental Therapeutics
4.
Breakthroughs in Cancer Care: From Rare Diagnoses to Advanced and Early-Stage Treatments
5.
Boosting Checkpoint Immunotherapy in Hodgkin Lymphoma with JAK Inhibition: Advances & Insights
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation